NCT07409337 Self-Acupressure for Primary Dysmenorrhea and Premenstrual Symptoms
| NCT ID | NCT07409337 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Nigde Omer Halisdemir University |
| Condition | Primary Dysmenorrhea |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2026-02-15 |
| Primary Completion | 2026-08-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2026-02-15 with a primary completion date of 2026-08-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized, sham-controlled trial aims to evaluate the effects of self-administered acupressure on menstrual pain severity and premenstrual symptoms in women aged 18-30 years with primary dysmenorrhea. Participants will be randomly assigned to either a self-acupressure intervention group or a sham self-acupressure control group. The intervention will be applied during the premenstrual and menstrual periods over approximately six months. The primary outcome is the change in menstrual pain severity, and secondary outcomes include changes in premenstrual symptom severity, analgesic use, and menstruation-related activity limitation.
Eligibility Criteria
Inclusion Criteria: * Female participants aged 18 to 30 years * Regular menstrual cycles (21-35 days) * Diagnosis of primary dysmenorrhea with moderate to severe menstrual pain * Presence of premenstrual symptoms consistent with premenstrual syndrome * Currently enrolled as a university student * Willingness to perform self-acupressure as instructed for approximately six menstrual cycles * Ability to understand the study procedures and provide written informed consent Exclusion Criteria: * Secondary dysmenorrhea (e.g., endometriosis, uterine fibroids, pelvic inflammatory disease) * Current use of hormonal contraceptives or hormonal therapy within the past 3 months * Pregnancy or breastfeeding * Chronic gynecological, endocrine, or systemic disease that may affect menstrual pain or symptoms * Regular use of analgesic or anti-inflammatory medications outside menstruation * Prior formal training or regular practice of acupuncture or acupressure * Inability to comply with study procedures or follow-up schedule
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07409337 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 30 Years, studying Primary Dysmenorrhea. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07409337 currently recruiting?
Yes, NCT07409337 is actively recruiting participants. Contact the research team at drpinarerdogan@gmail.com for enrollment information.
Where is the NCT07409337 trial being conducted?
This trial is being conducted at Niğde, Turkey (Türkiye).
Who is sponsoring the NCT07409337 clinical trial?
NCT07409337 is sponsored by Nigde Omer Halisdemir University. The trial plans to enroll 120 participants.